Navigation Links
Cranberry-Active Proven to Treat and Prevent Vaginal Infections
Date:4/22/2013

AMSTERDAM, April 22, 2013 /PRNewswire/ --

Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts

Instead of traditional treatment with antibiotics or chemical substances, vaginal infections can be treated and prevented by using Cranberry-Active tablets, developed by Dutch company Medical Brands. The company has obtained a European Class IIa Medical Device Status for its patented Cranberry-Active tablet, making it the first and only cranberry-based product in Europe which has a proven medical claim to treat and prevent vaginal infections.

After the successful introduction of Cranberry-Active capsules for the treatment of bladder- and urinary tract infections in 2012, Medical Brands and American company NATUREX-DBS together have introduced their latest development for treatments of vaginal infections.

,,Vaginal Infections are a serious health problem, affecting one of every three women during their lifetime," says Maikel Hendriks, president of Medical Brands. ,,After the first treatment, another 30 percent will suffer from re-occurrence within three months and 80 percent within nine months."

While the claims of other cranberry-based food supplements and pro-biotic vaginal products have been rejected by the European Food and Safety Authority (EFSA), Medical Brands produced studies which clinically showed that the Cranberry-Active treats and prevents vaginal infections. The product can be freely sold as a self-care medical device on the OTC market in all European countries.

Maikel Hendriks: ,,Our Cranberry-Active marketing authorization is the culmination of years of planning, development and clinical investigation. We answer to a growing global push towards safe and natural solutions as the resistance to antibiotics continues to rise."

His company is specialised in developing self-care medical devices without pharmacologic effects. It provides consumers with solutions for everyday diseases without the side effects that most drugs have.

In the Netherlands and Scandinavia the tablet is sold as the Vaginal Infection Tablet by 'i say'. In other countries Medical Brands is still searching for partners to distribute the products.


'/>"/>
SOURCE Medical Brands
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cranberry-Active démontre sa capacité à traiter et prévenir les infections vaginales
2. Cranberry-Active wirksam zur Behandlung und Vorbeugung vaginaler Infektionen
3. Cranberry Capsule Proven to Cure Bladder Infection
4. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
5. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
6. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
7. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
8. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
11. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):